Literature DB >> 19679184

Effects of liquisolid formulations on dissolution of naproxen.

Ngiik Tiong1, Amal A Elkordy.   

Abstract

The aim of this study was to investigate the use of liquisolid technique in improving the dissolution profiles of naproxen in a solid dosage form. This study was designed to evaluate the effects of different formulation variables, i.e. type of non-volatile liquid vehicles and drug concentrations, on drug dissolution rates. The liquisolid tablets were formulated with three different liquid vehicles, namely Cremophor EL (polyoxyl 35 castor oil), Synperonic PE/L61 (poloxamer 181, polyoxyethylene-polyoxypropylene copolymer) and poly ethylene glycol 400 (PEG400) at two drug concentrations, 20%w/w and 40%w/w. Avicel PH102 was used as a carrier material, Cab-o-sil M-5 as a coating material and maize starch as a disintegrant. The empirical method as introduced by Spireas and Bolton (1999) [1] was applied strictly to calculate the amounts of coating and carrier materials required to prepare naproxen liquisolid tablets. Quality control tests, i.e. uniformity of tablet weight, uniformity of drug content, tablet hardness, friability test, disintegration and dissolution tests were performed to evaluate each batch of prepared tablets. In vitro drug dissolution profiles of the liquisolid formulations were studied and compared with conventional formulation, in simulated gastric fluid (pH 1.2) and simulated intestinal fluid (pH 7.2) without enzyme. Stability studies were carried out to evaluate the stability of the tablets under humid conditions. Differential scanning calorimetry and Fourier transform infrared were used to investigate physicochemical interaction between naproxen and the excipients. It was found that liquisolid tablets formulated with Cremophor EL at drug concentration of 20%w/w produced high dissolution profile with acceptable tablet properties. The stability studies showed that the dissolution profiles of liquisolid tablets prepared with Cremophor EL were not affected by ageing significantly. Furthermore, DSC revealed that drug particles in liquisolid formulations were completely solubilised.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19679184     DOI: 10.1016/j.ejpb.2009.08.002

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  22 in total

Review 1.  Multifunctional Role of Polyvinylpyrrolidone in Pharmaceutical Formulations.

Authors:  Yu Luo; Yanlong Hong; Lan Shen; Fei Wu; Xiao Lin
Journal:  AAPS PharmSciTech       Date:  2021-01-06       Impact factor: 3.246

2.  Investigating the use of liquisolid compacts technique to minimize the influence of pH variations on loratadine release.

Authors:  Mazen El-Hammadi; Nisrine Awad
Journal:  AAPS PharmSciTech       Date:  2011-11-19       Impact factor: 3.246

3.  Enhancement of Loperamide Dissolution Rate by Liquisolid Compact Technique.

Authors:  Kambham Venkateswarlu; Jami Komala Preethi; Kothapalli Bonnoth Chandrasekhar
Journal:  Adv Pharm Bull       Date:  2016-09-25

4.  Formulation Development of Mirtazapine Liquisolid Compacts: Optimization Using Central Composite Design.

Authors:  Faiza Naureen; Yasar Shah; Sayyed Ibrahim Shah; Muhammad Abbas; Inayat Ur Rehman; Salar Muhammad; Hamdullah Hamdullah; Khang Wen Goh; Fazli Khuda; Amjad Khan; Siok Yee Chan; Mehwish Mushtaq; Long Chiau Ming
Journal:  Molecules       Date:  2022-06-22       Impact factor: 4.927

5.  Application of liquisolid technology for enhancing solubility and dissolution of rosuvastatin.

Authors:  Pavan Ram Kamble; Karimunnisa Sameer Shaikh; Pravin Digambar Chaudhari
Journal:  Adv Pharm Bull       Date:  2013-12-24

6.  Enhancement of the Oral Bioavailability of Fexofenadine Hydrochloride via Cremophor(®) El-Based Liquisolid Tablets.

Authors:  Soad Ali Yehia; Mohamed Shafik El-Ridi; Mina Ibrahim Tadros; Nolwa Gamal El-Sherif
Journal:  Adv Pharm Bull       Date:  2015-11-30

7.  Liqui-Tablet: the Innovative Oral Dosage Form Using the Newly Developed Liqui-Mass Technology.

Authors:  Matthew Lam; Kofi Asare-Addo; Ali Nokhodchi
Journal:  AAPS PharmSciTech       Date:  2021-03-01       Impact factor: 3.246

8.  Liquisolid systems to improve the dissolution of furosemide.

Authors:  Babatunde Akinlade; Amal A Elkordy; Ebtessam A Essa; Sahar Elhagar
Journal:  Sci Pharm       Date:  2010-04-23

9.  In vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation.

Authors:  Bao Chen; Zhouhua Wang; Guilan Quan; Xinsheng Peng; Xin Pan; Rongchang Wang; Yuehong Xu; Ge Li; Chuanbin Wu
Journal:  Int J Nanomedicine       Date:  2012-01-06

10.  Formulation and characterization of ketoprofen liquisolid compacts by Box-Behnken design.

Authors:  G Vijayaranga Vittal; R Deveswaran; S Bharath; Bv Basavaraj; V Madhavan
Journal:  Int J Pharm Investig       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.